Dow Up 0.19% Nasdaq Up 0.56%

Cytokinetics, Incorporated (CYTK)

-NasdaqCM
4.14 Down 0.02(0.48%) 4:00PM EST
Prev Close:4.16
Open:4.12
Bid:N/A
Ask:12.00 x 400
1y Target Est:11.60
Beta:1.84
Earnings Date:Jan 26 - Jan 30 (Est.)
Day's Range:4.11 - 4.24
52wk Range:3.05 - 13.26
Volume:279,738
Avg Vol (3m):341,454
Market Cap:151.56M
P/E (ttm):N/A
EPS (ttm):-0.49
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
CYTKDown 0.48%151.56M
BIIBDown 1.49%70.63B
LGNDDown 0.72%1.07B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):3.07
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.90
Quarterly EPS Est (Dec-14) :-0.25
Mean Recommendation*:2.2
PEG Ratio (5 yr expected):-0.31

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Cytokinetics, Incorporated, a clinical stage biopharmaceutical company, focuses on the discovery and development of novel small molecule therapeutics that modulate muscle function for the potential treatment of serious diseases and medical conditi... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback